pe
pep-04676 v1 CC-BY-SA-4.0

Blood-pressure-lowering peptide (AVESTVATL)

A natural peptide that blocks ACE, the enzyme that raises blood pressure, potentially helping to lower it. Experimental, not yet an approved drug.

statusbioassayed targetACE length9 aa refs1
anti-hypertensive
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 1.0
ipTM0.412
pTM0.405
avg pLDDT77.1
ranking score0.699
STRUCTURE · PEP-04676 × ACE
ranking0.699
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence9 aa
159
AVESTVATL
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.4118700921535492 boltz-2
ranking score 0.6993557214736938 boltz-2
structural qualityopenfold3
metricvaluenote
gpde2.567global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Ala-Val-Glu-Ser-Thr-Val-Ala-Thr-Leu
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Blood-pressure-lowering peptide (AVESTVATL) (pep-04676, v1). PeptideModel. https://peptidemodel.com/card/pep-04676
@peptide{pep04676,
  sequence = {AVESTVATL},
  target   = {ace},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 3 by signal overlap
references 1 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use